Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Pancreatic cancer
RAS(ON) inhibitors, pan-KRAS and the long wait for a second-line standard.
SITC Annual Meeting 2026
4–8 Nov 2026, Phoenix · Journal for ImmunoTherapy of Cancer 14 (Suppl 2 and 3), open access
1,109 regular and 19 late-breaking abstracts are in Crossref as open-access JITC supplement records (CC BY-NC); the supplement may still be filling in.
Indexed in Crossref
2 abstracts matching pancreatic cancer from the meeting's journal supplement, fetched live from Crossref 2026-11-12 11:19 UTC. This is a keyword search, not the complete abstract book.
- 175Claudin 18.2 expression in PDAC: KRAS independence and stage IV prognostic valueSacha El Khoury, Dan Zhao
- 745Spatial enrichment of tumor-associated macrophage subsets near cancer-associated fibroblasts identifies distinct stromal niches in PDACNatalie K Horvat, Alexis F Dixon, Erin E Grundy, Brian Robinson et al.